Position in ICLR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,348,149
+$4,418,085 QoQ
Shares Held
191,976
-26.6% QoQ
Ownership
0.249%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#58
of 422 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026RAYMOND JAMES FINANCIAL INC holds $1,810,723,119 across 28 Diagnostics & Research names. ICLR ranks #13 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
779,661 | $390,890,837 | |
| 2 | DHR |
Danaher Corp /De/
|
1,515,515 | $288,675,296 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
1,037,428 | $200,451,836 | |
| 4 | NTRA |
Natera, Inc.
|
593,083 | $160,992,378 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
262,791 | $138,343,692 | |
| 6 | DGX |
Quest Diagnostics Inc
|
505,762 | $107,196,254 | |
| 7 | A |
Agilent Technologies, Inc.
|
636,252 | $84,513,350 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
126,182 | $66,824,723 |
All Filings in ICLR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,348,149 | 191,976 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $28,930,064 | 261,432 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $34,823,516 | 191,107 | Shares | Defined | 2026-02-18 | |
| 2025-09-30 | $39,267,550 | 224,386 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $26,147,254 | 179,768 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $25,987,238 | 148,507 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $35,820,983 | 170,812 | Shares | Defined | 2025-04-23 | |
| No filing history on record for this holder in this stock. | ||||||